Professor Robert Clarke
- Causes and consequences of heart failure in Chinese adults (MRC PHRU)
- Causes and consequences of frailty in 0.5M adults living in China
- Patterns, determinants and prognosis of multi-morbidity associated with major cardiometabolic diseases in Chinese adults
- Prediction of cardiovascular disease in 0.5M adults living in the UK: evaluation of novel risk factors using modern statistical approaches
MD, FRCP, FFPH, FFPHI, MSc, DCH
Professor of Epidemiology and Public Health Medicine
- Clinical Trial Service Unit and Epidemiological Studies Unit
Robert Clarke is a Professor of Epidemiology and Public Health Medicine at the Clinical Trial Service Unit (CTSU), Nuffield Department of Population Health, University of Oxford and Consultant in Public Health Medicine and Director of the MSc course in Global Health Science. He qualified in clinical medicine in Ireland and worked for 5 years in internal medicine and 4 years in cardiology. After 2 years in clinical pharmacology at Vanderbilt University, Nashville, USA, he joined CTSU in 1991 and specialised in Cardiovascular Epidemiology.
His main research interests are to understand the importance of classical and novel risk factors for occlusive vascular diseases. He led several large observational studies and meta-analyses of observational studies and randomized trials (eg, Whitehall study, PROCARDIS, CARDIoGRAMplusC4D, B-Vitamin Treatment Trialists’ Collaboration and the BEST-D trial). He also worked extensively on the Prospective Studies Collaboration and the China Kadoorie Biobank (CKB) study. He currently leads a research programme to assess the importance of blood pressure, blood lipids, and novel biomarkers (including genetic markers, cytokines, proteomics and metabolomics) for occlusive vascular diseases in the CKB study. His work has been widely cited (200 publications, H-index of 54) and is listed in Tomson Reuters’ Most Influential Scientific Minds 2014.
Risks of ischaemic heart disease and stroke in meat eaters, fish eaters, and vegetarians over 18 years of follow-up: results from the prospective EPIC-Oxford study.
Tong TYN. et al, (2019), BMJ, 366
Vitamin D and cause-specific vascular disease and mortality: a Mendelian randomisation study involving 99,012 Chinese and 106,911 European adults.
Huang T. et al, (2019), BMC Med, 17
General and Abdominal Adiposity and Mortality in Mexico City: Prospective Study of 150 000 Adults.
Gnatiuc L. et al, (2019), Ann Intern Med
Beneficial Effects of Milk Consumption on Lean Body Mass.
Clarke R., (2019), Clin Chem, 65, 718 - 719
Assessment of the Role of Carotid Atherosclerosis in the Association Between Major Cardiovascular Risk Factors and Ischemic Stroke Subtypes.
Parish S. et al, (2019), JAMA Netw Open, 2